News Snapshot:
From Novavax starting its mid-stage study of COVID-19 vaccine in South Africa to China granting the country's first COVID-19 vaccine patent, here are all the latest updates on the COVID-19 vaccine and its candidates: Novavax begins mid-stage study of COVID-19 vaccine in South Africa US drug developer Novavax said on August 17 that it is starting a mid-stage study of its experimental COVID-19 vaccine in South Africa as the country experiences a surge in coronavirus cases. The Phase 2b trial study of NVX-CoV2373 will be conducted on 2,665 healthy adults and will evaluate the safety and immunogenicity in about 240...
